Drugmaker Merck announced it will refund 340B covered entities for certain overcharges.
Merck Offers Refunds to 340B Providers for Overcharges of Inhaler in Fourth Notice This Year
Views
Pharmaceutical manufacturer Merck has announced it will refund 340B covered entities for certain overcharges of its inhaler, Proventil HFA, during [...]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.